litlas
Log inCreate account

Gerhard Ehninger

Active 1985–2025

195
Papers
35,522
Citations
104
h-index
195
i10-index

Citations

Citations per year for Gerhard Ehninger1979: 1 citations1986: 1 citations1987: 2 citations1989: 2 citations1990: 3 citations1991: 3 citations1992: 1 citations1993: 7 citations1994: 8 citations1995: 6 citations1996: 4 citations1997: 10 citations1998: 14 citations1999: 21 citations2000: 48 citations2001: 49 citations2002: 73 citations2003: 113 citations2004: 141 citations2005: 188 citations2006: 182 citations2007: 216 citations2008: 193 citations2009: 201 citations2010: 218 citations2011: 183 citations2012: 215 citations2013: 226 citations2014: 299 citations2015: 245 citations2016: 295 citations2017: 296 citations2018: 266 citations2019: 1,247 citations2020: 1,313 citations2021: 1,246 citations2022: 934 citations2023: 816 citations2024: 1,001 citations2025: 419 citations2026: 5 citations1980–1985: no citations, so these years are not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,281 citing papers, 23.8% of this breakdownGermany: 1,494 citing papers, 10.8% of this breakdownChina: 981 citing papers, 7.1% of this breakdownUnited Kingdom: 834 citing papers, 6% of this breakdownItaly: 810 citing papers, 5.9% of this breakdownFrance: 735 citing papers, 5.3% of this breakdownNetherlands: 471 citing papers, 3.4% of this breakdownSpain: 436 citing papers, 3.2% of this breakdownCanada: 412 citing papers, 3% of this breakdownJapan: 366 citing papers, 2.7% of this breakdownAustralia: 339 citing papers, 2.5% of this breakdownSwitzerland: 327 citing papers, 2.4% of this breakdown
0%23.8%Other 23.9%

Institutions

Fields

  • Medicine75.8%
  • Biochemistry, Genetics and Molecular Biology16.9%
  • Immunology and Microbiology4.1%
  • Engineering0.5%
  • Neuroscience0.5%
  • Materials Science0.5%
  • Other1.7%

Topics

  • Acute Myeloid Leukemia Research13.4%
  • Hematopoietic Stem Cell Transplantation6.7%
  • Acute Lymphoblastic Leukemia research4.2%
  • Chronic Myeloid Leukemia Treatments4.2%
  • CAR-T cell therapy research2.9%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment2.6%
  • Other66%

Coauthors

All papers

Open in search
  1. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Authors: Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford, Kristina Laumann, Susan M. Geyer, Clara D. Bloomfield, Christian Thiede, Thomas W. Prior, Konstanze Döhner, Guido Marcucci, Francesco Lo‐Coco, Rebecca B. Klisovic, Andrew H. Wei, Jorge Sierra, Miguel Á. Sanz, Joseph Brandwein, Théo de Witte, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Jürgen Krauter, Richard F. Schlenk, Arnold Ganser, Hubert Serve, Gerhard Ehninger, Sergio Amadori, Richard A. Larson, Hartmut Döhner - New England Journal of Medicine 2017 cited by 2,198

  2. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

    Authors: Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, Christian Thiede, Sonia Maria Orlando, Simona Iacobelli, Felicetto Ferrara, Paola Fazi, Laura Cicconi, Eros Di Bona, Giorgina Specchia, Simona Sica, Mariadomenica Divona, Alessandro Levis, Walter Fiedler, Elisa Cerqui, Massimo Breccia, Giuseppe Fioritoni, Helmut R. Salih, Mario Cazzola, Lorella Melillo, Angelo Michele Carella, Christian Brandts, Enrica Morra, Marie von Lilienfeld‐Toal, Bernd Hertenstein, Mohammed Wattad, Michael Lübbert, Matthias Hänel, Norbert Schmitz, Hartmut Link, Maria Grazia Kropp, Alessandro Rambaldi, Giorgio La Nasa, Mario Luppi, Fabio Ciceri, Olimpia Finizio, Adriano Venditti, Francesco Fabbiano, Konstanze Döhner, Michaela Sauer, Arnold Ganser, Sergio Amadori, Franco Mandelli, Hartmut Döhner, Gerhard Ehninger, Richard F. Schlenk, Uwe Platzbecker - New England Journal of Medicine 2013 cited by 1,606

  3. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    Authors: Andreas Burchert, Gesine Bug, Lea Fritz, Jürgen Finke, Matthias Stelljes, Christoph Röllig, Ellen Wollmer, Ralph Wäsch, Martin Bornhäuser, Tobias Berg, Fabian Lang, Gerhard Ehninger, Hubert Serve, Robert Zeiser, Eva-Maria Wagner, Nicolaus Kröger, Christine Wolschke, Michael Schleuning, Katharina S. Götze, Christoph Schmid, Martina Crysandt, Eva Eßeling, Dominik Wolf‎, Ying Wang, Alexandra Böhm, Christian Thiede, Torsten Haferlach, Christian Michel, Wolfgang Bethge, Thomas Wündisch, Christian Brandts, Susanne Harnisch, Michael Wittenberg, Heinz‐Gert Hoeffkes, Susanne Rospleszcz, Alexander Burchardt, Andreas Neubauer, Markus Brugger, Konstantin Strauch, Carmen Schade‐Brittinger, Stephan Metzelder - Journal of Clinical Oncology 2020 cited by 551

  4. Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML

    Authors: Martin Wermke, Sabrina Kraus, Armin Ehninger, Ralf C. Bargou, Maria-Elisabeth Goebeler, Jan Moritz Middeke, Carla Kreissig, Malte von Bonin, Jan Koedam, Michael Pehl, Martin Bornhäuser, Hermann Einsele, Gerhard Ehninger, Marc Cartellieri - Blood 2021 cited by 164

  5. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

    Authors: Simon Raffel, Mattia Falcone, Niclas Kneisel, Jenny Hansson, Wei Wang, Christoph Lutz, Lars Bullinger, Gernot Poschet, Yannic Nonnenmacher, Andrea Barnert, Carsten Bahr, Petra Zeisberger, Adriana Przybylla, Markus Sohn, Martje Tönjes, Ayelet Erez, Lital N. Adler, Patrizia Jensen, Claudia Scholl, Stefan Fröhling, Sibylle Cocciardi, Patrick Wuchter, Christian Thiede, Anne Flörcken, Jörg Westermann, Gerhard Ehninger, Peter Lichter, Karsten Hiller, Rüdiger Hell, Carl Herrmann, Anthony D. Ho, Jeroen Krijgsveld, Bernhard Radlwimmer, Andreas Trumpp - Nature 2017 cited by 353

  6. Acute myeloid leukaemia

    Authors: Asim Khwaja, Magnus Björkholm, Rosemary E. Gale, Ross L. Levine, Craig T. Jordan, Gerhard Ehninger, Clara D. Bloomfield, Eli Estey, Alan K. Burnett, Jan J. Cornelissen, David A. Scheinberg, Didier Bouscary, David C. Linch - Nature Reviews Disease Primers 2016 cited by 587

  7. Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts

    Authors: Marc Cartellieri, Anja Feldmann, Stefanie Koristka, Claudia Arndt, Simon Loff, Armin Ehninger, Malte von Bonin, Elham Pishali Bejestani, Gerhard Ehninger, Michael Bachmann - Blood Cancer Journal 2016 cited by 249

  8. Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

    Authors: Armin Ehninger, Michael Krämer, Christoph Röllig, Christian Thiede, Martin Bornhäuser, Malte von Bonin, Martin Wermke, Anja Feldmann, Michael Bachmann, Gerhard Ehninger, Uta Oelschlägel, on behalf of the Study Alliance Leukemia - Blood Cancer Journal 2014 cited by 352

  9. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

    Authors: Uwe Platzbecker, Jan Moritz Middeke, Katja Sockel, Regina Herbst, Dominik Wolf‎, Claudia D. Baldus, Uta Oelschlägel, Anke Mütherig, Lars Fransecky, Richard Noppeney, Gesine Bug, Katharina S. Götze, Alwin Krämer, Tilmann Bochtler, Matthias Stelljes, Christoph Groth, Antje Schubert, Marika Mende, Friedrich Stölzel, Christine Borkmann, Anne Sophie Kubasch, Malte von Bonin, Hubert Serve, Mathias Hänel, Ulrich Dührsen, Johannes Schetelig, Christoph Röllig, Michael Krämer, Gerhard Ehninger, Martin Bornhäuser, Christian Thiede - The Lancet Oncology 2018 cited by 354

  10. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

    Authors: Franziska Taube, Julia Annabell Georgi, Michael Krämer, Sebastian Stasik, Jan Moritz Middeke, Christoph Röllig, Utz Krug, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Tim H. Brümmendorf, Ralph Naumann, A. Petzold, Roger Mulet‐Lazaro, Peter J.M. Valk, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer‐Eckart, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Sylvia Herold, Friedrich Stölzel, Katja Sockel, Malte von Bonin, Carsten Müller‐Tidow, Uwe Platzbecker, Wolfgang E. Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede, for the Study Alliance Leukemia (SAL) - Blood 2021 cited by 164

  11. Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Authors: Claudio Anasetti, Brent R. Logan, Stephanie J. Lee, Edmund K. Waller, Daniel J. Weisdorf, John R. Wingard, Corey Cutler, Peter Westervelt, Ann Woolfrey, Stephen Couban, Gerhard Ehninger, Laura Johnston, Richard T. Maziarz, Michael A. Pulsipher, David Porter, Shin Mineishi, John M. McCarty, Shakila P. Khan, Paolo Anderlini, William Bensinger, Susan F. Leitman, Scott D. Rowley, Christopher Bredeson, Shelly L. Carter, Mary M. Horowitz, Dennis L. Confer - New England Journal of Medicine 2012 cited by 905

  12. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

    Authors: Christian Thiede, Christine Steudel, Brigitte Mohr, Markus Schaich, Ulrike Schäkel, Uwe Platzbecker, Martin Wermke, Martin Bornhäuser, Markus Ritter, Andreas Neubauer, Gerhard Ehninger, Thomas Illmer - Blood 2002 cited by 1,729

  13. Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia

    Authors: Simon Loff, Josephine Dietrich, Jan-Erik Meyer, Julia Riewaldt, Johannes Spehr, Malte von Bonin, Cordula Gründer, Mridula Swayampakula, Kristin Franke, Anja Feldmann, Michael Bachmann, Gerhard Ehninger, Armin Ehninger, Marc Cartellieri - Molecular Therapy — Oncolytics 2020 cited by 103

  14. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

    Authors: Christoph Röllig, Hubert Serve, Andreas Hüttmann, Richard Noppeney, Carsten Müller‐Tidow, Utz Krug, Claudia D. Baldus, Christian Brandts, Volker Kunzmann, Hermann Einsele, Alwin Krämer, Kerstin Schäfer‐Eckart, Andreas Neubauer, Andreas Burchert, Aristoteles Giagounidis, Stefan W. Krause, Andréas Mackensen, Walter E. Aulitzky, Regina Herbst, Mathias Hänel, Alexander Kiani, Norbert Frickhofen, Johannes Kullmer, Ulrich Kaiser, Hartmut Link, Thomas Geer, A. Reichle, Christian Junghanß, Roland Repp, Frank Heits, Heinz Dürk, Jana Hase, Ina‐Maria Klut, Thomas Illmer, Martin Bornhäuser, Markus Schaich, Stefani Parmentier, Martin Görner, Christian Thiede, Malte von Bonin, Johannes Schetelig, Michael Krämer, Wolfgang E. Berdel, Gerhard Ehninger - The Lancet Oncology 2015 cited by 400

  15. Rapamycin extends murine lifespan but has limited effects on aging

    Authors: Frauke Neff, Diana Flores-Dominguez, Devon Ryan, Marion Horsch, Susanne Schröder, Thure Adler, Luciana Caminha Afonso, Juan Antonio Aguilar‐Pimentel, Lore Becker, Lillian Garrett, Wolfgang Hans, Moritz M. Hettich, Richard Holtmeier, Sabine M. Hölter, Kristin Moreth, Cornelia Prehn, Oliver Puk, Ildikó Rácz, Birgit Rathkolb, Jan Rozman, Beatrix Naton, Rainer Ordemann, Jerzy Adamski, Johannes Beckers, Raffi Bekeredjian, Dirk H. Busch, Gerhard Ehninger, Jochen Graw, Heinz Höfler, Martin Klingenspor, Thomas Klopstock, Markus Ollert, Jörg Stypmann, Eckhard Wolf, Wolfgang Wurst, Andreas Zimmer, Helmut Fuchs, Valérie Gailus‐Durner, Martin Hrabě de Angelis, Dan Ehninger - Journal of Clinical Investigation 2013 cited by 379

  16. Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Authors: Christoph Schmid, Myriam Labopin, Arnon Nagler, Martin Bornhäuser, Jürgen Finke, Athanasios Fassas, Liisa Volin, Günhan Gürman, Johan Maertens, Pierre Bordigoni, Ernst Holler, Gerhard Ehninger, Emmanuelle Polge, Norbert Claude Gorin, Hans-Jochem Kolb, Vanderson Rocha - Journal of Clinical Oncology 2007 cited by 516

  17. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

    Authors: Konstanze Döhner, Christian Thiede, Nikolaus Jahn, Ekaterina Panina, Agnes Gambietz, Richard A. Larson, Thomas W. Prior, Guido Marcucci, Dan Jones, Jürgen Krauter, Michael Heuser, Maria Teresa Voso, Tiziana Ottone, Josep Nomdedéu, Sumithra J. Mandrekar, Rebecca B. Klisovic, Andrew H. Wei, Jorge Sierra, Miguel Á. Sanz, Joseph Brandwein, Théo de Witte, Joop H. Jansen, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Richard F. Schlenk, Arnold Ganser, Hubert Serve, Gerhard Ehninger, Sergio Amadori, Insa Gathmann, Axel Benner, Céline Pallaud, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield - Blood 2019 cited by 193

  18. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

    Authors: Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi, Christian Thiede, Francesca Paoloni, Marco Vignetti, Felicetto Ferrara, Mariadomenica Divona, Francesco Albano, Fabio Efficace, Paola Fazi, Marco Sborgia, Eros Di Bona, Massimo Breccia, Erika Borlenghi, Roberto Cairoli, Alessandro Rambaldi, Lorella Melillo, Giorgio La Nasa, Walter Fiedler, Peter Brossart, Bernd Hertenstein, Helmut R. Salih, Mohammed Wattad, Michael Lübbert, Christian Brandts, Mathias Hänel, Christoph Röllig, Norbert Schmitz, Hartmut Link, Chiara Frairia, Enrico Maria Pogliani, Claudio Fozza, Alfonso Maria D’Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Sergio Amadori, Franco Mandelli, Gerhard Ehninger, Richard F. Schlenk, Francesco Lo‐Coco - Journal of Clinical Oncology 2016 cited by 392

  19. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

    Authors: Stefanie Göllner, Thomas Oellerich, Shuchi Agrawal‐Singh, Tino Schenk, Hans‐Ulrich Klein, Christian Rohde, Caroline Pabst, Tim Sauer, Mads Lerdrup, Sigal Tavor, Friedrich Stölzel, Sylvia Herold, Gerhard Ehninger, Gabriele Köhler, Kuan‐Ting Pan, Henning Urlaub, Hubert Serve, Martin Dugas, Karsten Spiekermann, Binje Vick, Irmela Jeremias, Wolfgang E. Berdel, Klaus Hansen, Arthur Zelent, Claudia Wickenhauser, Lutz Müller, Christian Thiede, Carsten Müller‐Tidow - Nature Medicine 2016 cited by 267

  20. Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

    Authors: Mohamed A. Kharfan‐Dabaja, Myriam Labopin, Emmanuelle Polge, Taiga Nishihori, Ali Bazarbachi, Jürgen Finke, Michael Stadler, Gerhard Ehninger, Bruno Lioure, Nicolaas Schaap, Boris V. Afanasyev, Moshe Yeshurun, Cecilia Isaksson, Johan Maertens, Yves Chalandon, Christoph Schmid, Arnon Nagler, Mohamad Mohty - JAMA Oncology 2018 cited by 168

  21. Updated Results from a Phase I Dose Escalation Study of the Rapidly-Switchable Universal CAR-T Therapy UniCAR-T-CD123 in Relapsed/Refractory AML

    Authors: Martin Wermke, Stephan Metzelder, Sabrina Kraus, Elisa Sala, Vladan Vučinić, Walter Fiedler, Katrin Wetzko, Jonas Schäfer, Maria-Elisabeth Goebeler, Jan Koedam, Kristin Franke, Matti Vänskä, Armin Ehninger, Marc Cartellieri, Gerhard Ehninger, Tapan Maniar - Blood 2023 cited by 33

  22. Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3

    Authors: Thomas Fischer, Richard M. Stone, Daniel J. DeAngelo, Ilene Galinsky, Elihu H. Estey, Carlo Lanza, Edward Fox, Gerhard Ehninger, Eric J. Feldman, Gary J. Schiller, Virginia M. Klimek, Stephen D. Nimer, D. Gary Gilliland, Catherine Dutreix, Alice Huntsman-Labed, J. D. Virkus, Francis J. Giles - Journal of Clinical Oncology 2010 cited by 502

  23. Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro

    Authors: Joachim Oswald, Sabine Boxberger, Birgitte Jørgensen, Silvia Feldmann, Gerhard Ehninger, Martin Bornhäuser, Carsten Werner - Stem Cells 2004 cited by 1,303

  24. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)

    Authors: Christian Thiede, Sina Koch, Eva Creutzig, Christine Steudel, Thomas Illmer, Markus Schaich, Gerhard Ehninger, for the Deutsche Studieninitiative Leukämie (DSIL) - Blood 2006 cited by 726